Kilitch Drugs (India) Ltd.
Snapshot View

162.05 -2.25 ▼-1.4%

28 November 2022, 04:01:00 PM
Volume: 378

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kilitch.com
Market Cap 252.59 Cr.
Enterprise Value(EV) 256.96 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.48 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 29.58 Trailing Twelve Months Ending 2022-09
Industry PE 35.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 92.89 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.74 Calculated using Price: 162.05
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.56 Cr. 15,582,319 Shares
FaceValue 10
Company Profile
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.37%
1 Week
-1.22%
1 Month
-8.03%
3 Month
+0.06%
6 Month
+2.47%
1 Year
+4.48%
2 Year
+72.76%
5 Year
+86.37%
10 Year
+339.76%
9 years 2012-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 78.03 -0.25 -9.91 -8.59 4.95 3.36 0.71 3.09 4.73
Return on Capital Employed (%) 76.95 -0.74 -10.11 -8.69 6.08 7.59 1.95 4.40 7.26
Return on Assets (%) 46.26 -0.19 -9.25 -7.86 4.36 2.85 0.59 2.19 3.03

Balance Sheet View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 115 120 109 101 112 121 118 127 139 145
Non Curr. Liab. 1 -1 -1 -2 -2 -1 -1 -1 -1 -1
Curr. Liab. 60 7 8 12 15 20 22 73 69 64
Minority Int. 1 1 2 2 2 1 0
Equity & Liab. 177 126 116 110 126 143 142 202 208 208
Non Curr. Assets 10 79 68 62 63 78 86 122 94 104
Curr. Assets 167 47 47 49 63 65 56 80 114 104
Misc. Exp. not W/O 0 0
Total Assets 177 126 116 110 126 143 142 202 208 208

Profit Loss View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 108 19 21 29 51 82 53 69 114 135
Other Income 1 3 3 1 3 5 5 3 3 3
Total Income 109 22 24 30 54 88 58 71 117 138
Total Expenditure -95 -21 -25 -29 -46 -76 -53 -63 -104 -122
PBIDT 14 1 -2 1 9 11 5 8 13 16
Interest -3 0 0 0 0 -1 -1 -1 -1 -3
Depreciation -5 -2 -10 -10 -2 -2 -2 -2 -2 -3
Taxation -21 1 0 0 -1 -5 -1 -1 -3 -3
Exceptional Items 92
PAT 76 0 -11 -9 5 4 1 4 6 7
Minority Interest 1 0 1 2
Share Associate
Other Related Items
Consolidated Net Profit 77 0 -11 -9 5 4 1 4 7 9
Adjusted EPS 58 0 -8 -7 4 2 1 2 5 5

Cash Flow View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 22 -29 -8 17 1 1 0 4 46 6
Cash Fr. Inv. -24 41 -31 -20 -2 -4 -14 -10 -38 -15
Cash Fr. Finan. 7 -9 0 0 0 6 17 1 2 7
Net Change 6 2 -39 -2 0 2 3 -5 10 -2
Cash & Cash Eqvt 9 12 5 3 2 5 8 3 13 10

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 68.70 68.63 68.63 68.33 68.33 68.25 68.25 68.25 68.25
Public 31.30 31.37 31.37 31.67 31.67 31.75 31.75 31.75 31.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.97 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 28 Nov 2022
Disclosure Of Related Party Transactions For The Half Year Ended 30Th September 2022 Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 30th September 2022.
Wed, 16 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication pertaining to the extract of the financial results of the Company for the quarter ended 30th September 2022. The said extract of the financial results was published on Marathi and English edition on 15th November 2022.
Tue, 15 Nov 2022
Board Meeting Outcome for Approval Of Financial Results For The Period Ended 30Th September 2022
In continuation of our letter dated 3rd November 2022 and pursuant to Regulation 30 and Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday 14th November 2022 have considered and approved the following;

1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September 2022. The copy of Unaudited Financial Results (Standalone and Consolidated) as considered and approved by the Board of Directors along with Limited Review Report by the Auditors are enclosed herewith for your ready reference.

Technical Scans View Details >>

Mon, 28 Nov 2022
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Kilitch Drugs (India) Ltd.

What is Kilitch Drugs(India) share price?

Can I buy Kilitch Drugs(India) shares now?

What is the Market Cap of Kilitch Drugs(India)?

What are the key metrics to analyse Kilitch Drugs(India)?

What is the 52 Week High and Low of Kilitch Drugs(India)?

What is the trend of Kilitch Drugs(India) share price?